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Introduction and Aims
• Adulterated cocaine/levamisole has been increasingly used during the last decades around the world.
• Levamisole can cause skin lesions, intravascular thrombosis, neutropenia, and renal involvement, which are frequently missed in the clinical evaluation of these patients.
•
Increased patient and physician awareness is essential to ensuring proper diagnosis and treatment.
• We describe a series of five cases in patients of southern Brazil who were chronic users of cocaine/levamisole and presented skin lesions and/or acute kidney injury.
Patient´s medical records were reviewed and demographic, clinical and laboratorial data were extracted. • Serial urine samples were collected for cocaine and levamisole toxicological analysis; the samples were analyzed by immunochromatographic drug screen test (Abon, Biopharm, China). Confirmatory testing was performed by gas-chromatography-mass spectrometry (GC/MS) in an Agilent 7890A/5975C system (Wilmington, DE, USA).
• Patients characteristics and follow up are shown in table 1. Four patients exhibited retiform purpura in extremities (Fig.1) , and one of them had focal skin necrosis in the ear lobes. Four had elevated serum creatinine, proteinuria, severe anemia, and all patients had positive circulating anti-neutrophil cytoplasmatic antibodies (ANCA). In one patient it was possible to measure serum anti-myeloperoxidase and anti-proteinase 3 antibodies, and both were positive. The four patients with renal manifestations were submitted to percutaneous kidney biopsy that showed pauci-immune crescentic glomerulonephritis, with glomerular crescents, necrosis, and diffuse inflammation (Fig.2 ).
The presence of levamisole and cocaine in serial urine samples was confirmed in all five patients. The patients were advised to quit cocaine use, but only one stopped the ilicit drugs, as confirmed in subsequent measurements. • Four of the patients were treated with immunosuppressive therapy consisting of corticosteroids and monthly intravenous pulses of cyclophosphamide, due to the severity of the crescentic glomerulonephritis. • One patient developed end-stage renal disease, requiring renal replacement therapy. The patient with vasculitis restricted to skin was later admitted with acute kidney injury and mesenteric ischemia (still in use of cocaine), and died in the second day of hospitalization from a septic shock due to intestinal perforation. The other three patients showed improved renal function during treatment, with in hospital serum creatinine varying from 2,7 to 4,8 mg/dL, and in outpatient follow-up varying from 0,9 to 1,5 mg/dL. Three of four patients with renal vasculitis maintained cocaine/levamisole abuse as confirmed by urine sample analysis, despite their referred abstinence. The only patient with confirmed abstinence remitted the clinical manifestations.
• Cocaine/levamisole-induced vasculitis should be suspected in the presence of acute renal failure and skin lesions, even when drug abuse is denied, and especially when associated with retiform purpura. • A urine drug toxicology screen is necessary to confirm the diagnosis and must be done during patient follow-up to ascertain drug abstinence. • Drug abstinence, and in selected cases immunosuppressive therapy, are the best treatment strategy, and they seem to be associated with better clinical outcomes. 
Conclusions
